KEGG pathway analysis showed that CMTM6 coexpressed genes were remarkedly enriched in the ribosome, neurotrophin signaling pathway, and pathways in prostate cancer and glioma (Figure 7C; Supplementary Table S3). This evidence concerns the gene CMTM6 and prostate carcinoma.